Nouvelles

Une étude indépendante montre que Pillcheck améliore le traitement de la dépression et de l’anxiété

14 juin 2024

Un essai clinique randomisé mené dans trois pharmacies communautaires montre que les personnes souffrant de dépression et d’anxiété se rétablissent plus vite lorsque leurs médicaments...

New Pillcheck Study in Long Term Care shows the potential benefit of matching people’s drug treatment to their DNA in Elder Care

27 sept. 2023

A study involving Pillcheck in four long-term care homes found that 80% of older residents take two or more medications that can be tailored to...

Pillcheck a remporté le prix 2023 de la Société de l’arthrite du Canada. L’innovation est essentielle pour améliorer la prise en charge de l’arthrite.

17 août 2023

Pillcheck figure parmi les quatre lauréats des prix Idéateurs 2023 de la Société de l’arthrite du Canada, pour son approche de prescription guidée par l’ADN...

Pillcheck: Optimizing Medication Plans for Seniors with Dementia

19 janv. 2022

A Centre for Aging + Brain Health Innovation (CABHI) study found that Pillcheck helped identify ineffective or high-risk medications for long-term care residents with dementia....

Le rôle de la pharmacogénétique pour les promoteurs de régime d’assurance

22 sept. 2021

La COVID a accéléré l’évolution des services d’assurance maladie. Découvrez comment la pharmacogénétique aide les participants de régime à obtenir les bons médicaments pour se...

Pillcheck PGx launches new program for benefits advisors on the heels of positive study results in the mental health area

22 sept. 2021

Following positive study results in anxiety and depression, Pillcheck launched a program that gives benefits advisors and plans access to its pharmacogenetic medication management service...

Pharmacogenetic Testing May Improve Drug Treatments and Shorten Disability

22 sept. 2021

This Benefits Quarterly article describes how pharmacogenetic testing can benefit private health plans, benefits managers, care providers and members, with results from a community pharmacy...

Do Genetic Tests Belong in Benefit Plans?

22 sept. 2021

Genetic tests can offer insights into ancestry, disease risk and medication response. Pillcheck CEO Veronika Litinski discusses the benefits of pharmacogenetics for benefit plans and...

GeneYouIn et la Canada Vie élargissent l’accès aux tests pharmacogénétiques

22 sept. 2021

En janvier 2021, GeneYouIn et la Canada Vie ont élargi leur relation : tous les clients de l’assurance maladie de la Canada Vie obtiennent un...

Can Pharmacogenetics (PGx) Help Your Members and Improve Plan Sustainability?

30 juin 2020

By helping doctors choose prescription drugs that suit each person's inherited genetic variations, pharmacogenetics may improve members' medical experience and reduce plan costs. Read the...

DNA Test Now Personalizes Your Meds, Featured on Global News

23 juin 2020

About half of prescription medications don't work as expected, and 95% of people carry gene variations that affect drug response. Watch Global News interview Pillcheck...